Distal Pancreatectomy for Body Pancreatic Ductal Adenocarcinoma: Is Splenectomy Necessary? A Propensity Score Matched Study.

Body pancreatic ductal adenocarcinoma Distal pancreatectomy Spleen preservation Splenectomy

Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
25 Mar 2024
Historique:
received: 11 01 2024
accepted: 10 03 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

The value of splenectomy for body localization (≥ 5 cm from spleen hilum) of pancreatic ductal adenocarcinoma (B-PDAC) is uncertain. This study assessed spleen-preserving distal pancreatectomy (SPDP) results for B-PDAC. This single-center study included patients who underwent SPDP (Warshaw's technique) or distal splenopancreactomy (DSP) for B-PDAC from 2008 to 2019. Propensity score matching was performed to balance SPDP and DSP patients regarding sex, age, American Society of Anesthesiologists (ASA), body mass index (BMI), laparoscopy, pathological features [American Joint Committee on Cancer (AJCC)/tumor node metastasis classification (TNM)], margins, and neoadjuvant/adjuvant therapies. A total of 129 patients (64 male, median age 68 years, median BMI 24 kg/m SPDP for B-PDAC is associated with less postoperative morbidity than DSP, without impairing oncological outcomes.

Sections du résumé

BACKGROUND BACKGROUND
The value of splenectomy for body localization (≥ 5 cm from spleen hilum) of pancreatic ductal adenocarcinoma (B-PDAC) is uncertain. This study assessed spleen-preserving distal pancreatectomy (SPDP) results for B-PDAC.
PATIENTS AND METHODS METHODS
This single-center study included patients who underwent SPDP (Warshaw's technique) or distal splenopancreactomy (DSP) for B-PDAC from 2008 to 2019. Propensity score matching was performed to balance SPDP and DSP patients regarding sex, age, American Society of Anesthesiologists (ASA), body mass index (BMI), laparoscopy, pathological features [American Joint Committee on Cancer (AJCC)/tumor node metastasis classification (TNM)], margins, and neoadjuvant/adjuvant therapies.
RESULTS RESULTS
A total of 129 patients (64 male, median age 68 years, median BMI 24 kg/m
CONCLUSION CONCLUSIONS
SPDP for B-PDAC is associated with less postoperative morbidity than DSP, without impairing oncological outcomes.

Identifiants

pubmed: 38526834
doi: 10.1245/s10434-024-15220-0
pii: 10.1245/s10434-024-15220-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Society of Surgical Oncology.

Références

Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.
doi: 10.1158/0008-5472.CAN-14-0155 pubmed: 24840647
Tempero MA, Malafa MP, Benson AB, et al. Pancreatic adenocarcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;15:1028.
doi: 10.6004/jnccn.2017.0131
Tol J, Gouma D, Bassi C, Dervenis C, Montorsi M, Adham M, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2014;156(3):591–600.
doi: 10.1016/j.surg.2014.06.016 pubmed: 25061003
Rottenstreich A, Kleinstern G, Spectre G, Da’as N, Ziv E, Kalish Y. Thromboembolic events following splenectomy: risk factors, prevention, management and outcomes. World J Surg. 2018;42:675–81.
doi: 10.1007/s00268-017-4185-2 pubmed: 28808782
Jaïs X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A, Fadel E, Dartevelle P, Simonneau G, Humbert M. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax. 2005;60:1031–4.
doi: 10.1136/thx.2004.038083 pubmed: 16085731 pmcid: 1747270
Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011;378(9785):86–97.
doi: 10.1016/S0140-6736(10)61493-6 pubmed: 21474172
Kristinsson SY, Gridley G, Hoover RN, Check D, Landgren O. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica. 2014;99(2):392–8.
doi: 10.3324/haematol.2013.092460 pubmed: 24056815 pmcid: 3912973
Sun LM, Chen HJ, Jeng LB, Li TC, Wu SC, Kao CH. Splenectomy and increased subsequent cancer risk: a nationwide population-based cohort study. Am J Surg. 2015;210(2):243–51.
doi: 10.1016/j.amjsurg.2015.01.017 pubmed: 25986002
Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM, et al. Risk Factors and mitigation strategies for pancreatic fistula after distal pancreatectomy: analysis of 2026 resections from the international, multi-institutional distal pancreatectomy study group. Ann Surg. 2019;269(1):143–9.
doi: 10.1097/SLA.0000000000002491 pubmed: 28857813
Shoup M, Brennan MF, McWhite K, Leung DHY, Klimstra D, Conlon KC. The value of splenic preservation with distal pancreatectomy. Arch Surg. 2002;137(2):164–8.
doi: 10.1001/archsurg.137.2.164 pubmed: 11822953
He Z, Qian D, Hua J, Gong J, Lin S, Song Z. Clinical comparison of distal pancreatectomy with or without splenectomy: a meta-analysis. PLoS One. 2014;9(3):e91593.
doi: 10.1371/journal.pone.0091593 pubmed: 24682038 pmcid: 3969315
Shi N, Liu SL, Li YT, You L, Dai MH, Zhao YP. Splenic preservation versus splenectomy during distal pancreatectomy: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):365–74.
doi: 10.1245/s10434-015-4870-z pubmed: 26493758
Pendola F, Gadde R, Ripat C, Sharma R, Picado O, Lobo L, et al. Distal pancreatectomy for benign and low grade malignant tumors: Short-term postoperative outcomes of spleen preservation-A systematic review and update meta-analysis. J Surg Oncol. 2017;115(2):137–43.
doi: 10.1002/jso.24507 pubmed: 28133818
Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013;20(3):375–81.
doi: 10.1007/s00534-012-0549-z pubmed: 22911134
Collard M, Marchese T, Guedj N, Cauchy F, Chassaing C, Ronot M, et al. Is routine splenectomy justified for all left-sided pancreatic cancers? histological reappraisal of splenic hilar lymphadenectomy. Ann Surg Oncol. 2019;26(4):1071–8.
doi: 10.1245/s10434-018-07123-8 pubmed: 30607766
Navez J, Marique L, Hubert C, Van Laethem JL, Komuta M, Maris C, et al. Distal pancreatectomy for pancreatic neoplasia: is splenectomy really necessary? A bicentric retrospective analysis of surgical specimens. HPB (Oxford). 2020;22(11):1583–9.
doi: 10.1016/j.hpb.2020.01.016 pubmed: 32067888
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative; the strengthening the reporting of observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.
doi: 10.1016/S0140-6736(07)61602-X
Ferrone CR, Konstantinidis IT, Sahani DV, Wargo JA, Fernandez-del Castillo C, Warshaw AL. Twenty-three years of the Warshaw operation for distal pancreatectomy with preservation of the spleen. Ann Surg. 2011;253(6):1136–9.
doi: 10.1097/SLA.0b013e318212c1e2 pubmed: 21394008
Dembinski J, Cannella R, Sauvanet A, Dokmak S. Laparoscopic spleen-preserving distal pancreatectomy with splenic vessels resection (laparoscopic Warshaw procedure). J Visc Surg. 2022;159(5):415–23.
doi: 10.1016/j.jviscsurg.2022.03.002 pubmed: 35491391
Grossman JG, Fields RC, Hawkins WG, Strasberg SM. Single institution results of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of pancreas in 78 patients. J Hepatobiliary Pancreat Sci. 2016;23(7):432–41.
doi: 10.1002/jhbp.362 pubmed: 27207482
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.
doi: 10.1097/SLA.0b013e3181b13ca2 pubmed: 19638912
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1–7.
doi: 10.1097/SLA.0b013e318296c732 pubmed: 23728278
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–91.
doi: 10.1016/j.surg.2016.11.014 pubmed: 28040257
Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20–5.
doi: 10.1016/j.surg.2007.02.001 pubmed: 17629996
Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–8.
doi: 10.1016/j.surg.2007.05.005 pubmed: 17981197
Kamarajah SK, Burns WR, Frankel TL, et al. Validation of the American Joint Commission on Cancer (AJCC) 8th edition Staging System for Patients with Pancreatic Adenocarcinoma: a Surveillance, Epidemiology and End Results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–30.
doi: 10.1245/s10434-017-5810-x pubmed: 28213792
Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, et al. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010;39(1):e48-54.
doi: 10.1097/MPA.0b013e3181bd5cfa pubmed: 19910836
Sahin TT, Fujii T, Kanda M, Nagai S, Kodera Y, Kanzaki A, et al. Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas. Pancreas. 2011;40(7):1029–33.
doi: 10.1097/MPA.0b013e3182207893 pubmed: 21705947
Malleo G, Maggino L, Nobile S, Casciani F, Cacciatori N, Paiella S, et al. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2020;46(1734–41):32.
Tanaka K, Kimura Y, Hayashi T, Ambo Y, Yoshida M, Umemoto K, et al. Appropriate lymph node dissection sites for cancer in the body and tail of the pancreas : a multicenter retrospective study. Cancers. 2022;14:4409.
doi: 10.3390/cancers14184409 pubmed: 36139569 pmcid: 9497245
Hrebinko K, Tohme S, Hoehn RS, AlMasri S, Khan S, Kaltenmeier C, Lee KK, Paniccia A, Zureikat A, Nassour I. A National assessment of optimal oncologic surgery for distal pancreatic adenocarcinomas. Pancreas. 2021;50:386–92.
doi: 10.1097/MPA.0000000000001786 pubmed: 33835970 pmcid: 8670387
Granieri S, Bonomi A, Frassini S, Gjoni E, Germini A, Kersik A, et al. Kimura’s vs Warshaw’s technique for spleen preserving distal pancreatectomy: a systematic review and meta-analysis of high-quality studies. HPB (Oxford). 2023;25:614–24.
doi: 10.1016/j.hpb.2023.02.009 pubmed: 36941150
Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg. 2017;265:277–83.
doi: 10.1097/SLA.0000000000001814 pubmed: 27280511
Milito P, Aiolfi A, Asti E, Rausa E, Bonitta G, Bonavina L. Impact of spleen preserving laparoscopic distal pancreatectomy on postoperative infectious complications: systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A. 2019;29:167–77.
doi: 10.1089/lap.2018.0738 pubmed: 30592691
Lee W, Hwang DW, Han HS, Han IW, Heo JS, Unno M, et al. Comparison of infectious complications after spleen preservation versus splenectomy during laparoscopic distal pancreatectomy for benign or low-grade malignant pancreatic tumors: a multicenter, propensity score-matched analysis. J Hepatobiliary Pancreat Sci. 2023;30(2):252–62.
doi: 10.1002/jhbp.1213 pubmed: 35766108
Leon P, Giannone F, Belfiori G, Falconi M, Crippa S, Boggi U, et al. The oncologic impact of pancreatic fistula after distal pancreatectomy for pancreatic ductal adenocarcinoma of the body and the tail: a multicenter retrospective cohort analysis. Ann Surg Oncol. 2021;28(6):3171–83.
doi: 10.1245/s10434-020-09310-y pubmed: 33156465
Salehi O, Vega EA, Kutlu OC, Krishnan S, Sleeman D, De La Cruz Munoz N, Alarcon SV, Kazakova V, Kozyreva O, Conrad C. Does a laparoscopic approach to distal pancreatectomy for cancer contribute to optimal adjuvant chemotherapy utilization? Ann Surg Oncol. 2021;28:8273–80.
doi: 10.1245/s10434-021-10241-5 pubmed: 34125349
Schwarz RE, Harrison LE, Conlon KC, Klimstra DS, Brennan MF. The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg. 1999;188:516–21.
doi: 10.1016/S1072-7515(99)00041-1 pubmed: 10235580
Korrel M, Jones LR, van Hilst J, Balzano G, Björnsson B, Boggi U, Bratlie SO, et al. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. 2023;6(31):100673.
doi: 10.1016/j.lanepe.2023.100673

Auteurs

Tatiana Codjia (T)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Christian Hobeika (C)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.
UMR Inserm 1275 CAP Paris-Tech, Hôpital Lariboisière, Université Paris-Cité, Paris, France.

Pierre Platevoet (P)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Riccardo Pravisani (R)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Safi Dokmak (S)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Béatrice Aussilhou (B)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Lancelot Marique (L)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Jérome Cros (J)

Department of Pathology, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

François Cauchy (F)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Mickael Lesurtel (M)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France.

Alain Sauvanet (A)

Department of HPB Surgery and Liver Transplantation, AP-HP, Beaujon Hospital, University of Paris Cité, Clichy, France. alain.sauvanet@aphp.fr.

Classifications MeSH